KDM1A and acute myeloid leukemia: Coincidently, it is reported that SP2509, a KDM1A antagonist, induces more apoptosis in mutant NPM1-expressing AML cells than those with mixed-lineage leukemia fusion oncoproteins (Fiskus et al., 2014).